You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. A new device to improve screening of corneal transplant tissue

    SBC: Sarver & Associates Inc            Topic: NEI

    Marous, James R. An Eye Bank Endothelial Cell Counter Abstract Procurement of donor corneal tissue for transplant use is an important social service undertaken by largely underfunded eye banks. Tissue is not only harvested, but must be screened for a myriad of issues that may make the tissue unsuitable for transplant or pose a health risk to the tissue recipient. Donor tissue may be rejected for ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Automated Identification and Sorting of Rare Earth Elements in an E-waste Recycling Stream

    SBC: National Recovery Technologies LLC            Topic: B

    Electronic waste (e-waste) is one of the most rapidly growing waste problems worldwide. Improper handling of e-waste results in vast amounts of toxic waste being sent to landfill and leaching into the water supply. Due to these concerns, e-waste recycling is a rapidly growing industry. Unfortunately, most current e-waste recycling processes rely on either manual hand sorting or differential densit ...

    SBIR Phase II 2014 Environmental Protection Agency
  3. A Wnt Modulator for Treatment of Age-related Macular Degeneration

    SBC: Charlesson, LLC            Topic: NEI

    PROJECT SUMMARY/ABSTRACT Age-related macular degeneration (AMD) is characterized by progressively decreased central vision and visual acuity and remains a leading cause of vision loss and blindness in aged Americans. Currently, the standard of care for AMD is intravitreal vascular endothelial growth factor (VEGF) inhibitors. Clinical studies have demonstrated that anti-VEGF drugs can slow or reve ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Corrosion Protection of High-Value Test&Evaluation Assets

    SBC: eSpin Technologies, Inc.            Topic: MDA13T010

    This STTR Phase I proposal proposes to design and develop reactive filter media using nanofiber technology to capture corrosion inducing particulate matter present in coastal region air. The fibrous filter media will be functionalized using ion exchange chemistry which is known to react with salt ions. The media will be characterized for its filtration performance, resistance to airflow, and dus ...

    STTR Phase I 2014 Department of DefenseMissile Defense Agency
  5. Development of Compounds for the Prevention and Treatment of Rhabdomyolysis

    SBC: Virtual Drug Development Inc.            Topic: NIDDK

    ? DESCRIPTION (provided by applicant): The goal of this Phase I STTR project is to establish the feasibility of developing a small-molecule therapeutic agent designed to prevent rhabdomyolysis-induced renal failure. Rhabdomyolysis accounts for 7% to 10% of cases of renal failure in the US. Rhabdomyolysis results from muscle injury that leads to the release of myoglobin, which is then deposited ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Holographic Virtual Anatomy Table

    SBC: Third Dimension Technologies LLC            Topic: NIGMS

    Project Summary/Abstract Medical students long ago gave up robbing graves for corpses, but students still need access to anatomy resources. While availability of traditional resources (e.g. cadavers, animals, etc.) is dwindling, emerging virtual alternatives are revolutionizing the practice of medicine. Interest in virtual aids derives from decades of success in aviation and the military. These in ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Label-free platform for applications in drug discovery

    SBC: SENSIQ TECHNOLOGIES, INC.            Topic: NCATS

    DESCRIPTION: Incremental improvements in label free screening technologies over the past decade have not produced the capability necessary to support the changing needs of drug discovery programs. Persistent artifacts related to non-specific binding, promiscuous binding, precipitation, complex binding, tubing retention, aggregation, and sub-optimally designed platforms continue to hinder progress ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease

    SBC: Immuno Technologies, Inc.            Topic: R

    DESCRIPTION Caused by Borrelia burgdorferi Lyme disease LD can affect the skin heart joints or nervous system leading to an array of largely non specific symptoms that overlap with those of other debilitating illnesses Disease progression can lead to development of conditions with unfavorable prognosis such as antibiotic refractory arthritis or Post Treatment Lyme disease Syndrome PTLDS ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Rabbit InMAD Discovery of Novel Biomarkers for POC Tuberculosis Diagnostic Assay

    SBC: Immuno-mycologics, Inc.            Topic: NIAID

    DESCRIPTION provided by applicant Tuberculosis TB is a chronic infectious disease that infects approximately one third of the worldandapos s population Eighty five percent of the estimated million new cases of TB in occurred in resource limited countries located in Asia and Africa In there were million deaths from TB among HIV negative patients and additional TB d ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Small blood pumps for small patients

    SBC: Vadovations, Inc.            Topic: NHLBI

    PROJECT SUMMARY/ABSTRACT Heart failure and congenital heart defects threaten the lives of several thousand children each year. The only FDA-approved long term pediatric heart support device is the Berlin Heart Excor, which is based on 30+ year old technology and is fraught with complications including blood clots forming in the device requiring frequent device replacement. The recipients of this ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government